Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > Hopefully on Monday, Dr Witkowski can update his Abstract

<< Previous

Bullboard Posts

Next >>

Post by steadfaston Jun 02, 2022 3:11pm

282 Views

Post# 34727412

Hopefully on Monday, Dr Witkowski can update his Abstract

To: Patient # 1 26 mos, Patient #2 8 months, Patient #3 6 mos ACHIEVED
      INSULIN INDEPENDENT
      SCP'S well tolerated with implant durations exceeding 36 months (3 years)
      (Just added from Phil's figures at AGM to now)
+    whatever else he may have
He has already concluded ITx with SCP demonstrated long term safety & efficacy
in an early subset of trial patients.

<< Previous

Bullboard Posts

Next >>

Rig Count Soars as Utilization Surpasses Industry Averages